← Back to all trials
Not Yet Recruiting
NCT07517224
Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer
Conditions: Breast Cancer Survivors
Sex: Female
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: Loyola University
Summary
The goal of this clinical trial is to assess the feasibility of an 8-week aerobic exercise program and its effect on arterial function in breast cancer survivors.
The main questions it aims to answer are:
* Is an 8-week aerobic exercise program feasible in breast cancer survivors after the completion of chemotherapy, immunotherapy and/or anti-HER2 agents?
* Is this 8-week aerobic exercise program beneficial for vascular function in breast cancer survivors?
Participants will:
* Begin an 8-week aerobic exercise program, three days per week, after the completion of chemotherapy, immunotherapy and/or anti-HER2 agents.
* Visit our facility three times: before the exercise program, 1 month after, and after the completion of the program.
* Complete questionnaires, physical functional tests, and body composition and vascular measurements at every visit.
Eligibility Criteria
Inclusion criteria:
1. Women (18-70 years) with a stage I-III breast cancer diagnosis who have completed chemotherapy, immunotherapy and/or anti-HER2 agents.
2. Able to begin aerobic exercise within 12 weeks of the final chemotherapy, immunotherapy and/or anti-HER2 agents.
3. Sedentary by self-reporting inactivity (\
Source: ClinicalTrials.gov (NCT07517224). StuddyBuddy aggregates publicly available trial information.
